Luperacus Overview
- Year Founded
-
2016
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
Luperacus General Information
Description
Operator of a biotechnology company based in the United Kingdom. The company has developed novel therapeutic antibodies to treat canine and human cancer, enabling medical professional to treat cancer in humans and dogs.
Contact Information
Website
www.luperacus.comCorporate Office
- 6 Riverside Court, Mayo Avenue
- Angus
- Dundee DD2 1XD
- Scotland, United Kingdom
Corporate Office
- 6 Riverside Court, Mayo Avenue
- Angus
- Dundee DD2 1XD
- Scotland, United Kingdom
Luperacus Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 01-Jan-2021 | Completed | Startup | |||
| 1. Early Stage VC | Completed | Startup |
Luperacus Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Innova Partnerships | Venture Capital | Minority |
Luperacus FAQs
-
When was Luperacus founded?
Luperacus was founded in 2016.
-
Where is Luperacus headquartered?
Luperacus is headquartered in Dundee, United Kingdom.
-
What industry is Luperacus in?
Luperacus’s primary industry is Drug Discovery.
-
Is Luperacus a private or public company?
Luperacus is a Private company.
-
What is Luperacus’s current revenue?
The current revenue for Luperacus is .
-
Who are Luperacus’s investors?
Innova Partnerships has invested in Luperacus.
-
When was Luperacus acquired?
Luperacus was acquired on 01-Jan-2021.
-
Who acquired Luperacus?
Luperacus was acquired by ABBio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process